NIH-funded research NIH-funded research

Understanding how disrupted lipid metabolism affects Alzheimer's disease

Official title: Disrupted Lipid Metabolism in Alzheimer's Disease

Funded at University of Arizona · NIH-10884782 · Data updated 2026-11-12

This study is looking at how the way our brain cells handle fats might affect Alzheimer's disease, with the hope of finding new ways to help people manage their symptoms and improve their brain health.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startMay 1, 2024
Project endApril 30, 2027
Funding year2024
Award (this year)$1,610,885
NIH project number1RF1AG079157-01A1
Project IDNIH-10884782 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk due to genetic or lifestyle factors.

Less likely to help

Patients with other forms of dementia unrelated to lipid metabolism may not receive benefit from this research.

What this research studies

This research investigates the role of lipid metabolism in Alzheimer's disease, focusing on how changes in fatty acid processing in brain cells, particularly astrocytes, may contribute to the onset and progression of the disease. By examining the mechanisms behind lipid dysregulation, the study aims to uncover potential pathways that lead to neuroinflammation and cognitive decline associated with Alzheimer's. Patients may benefit from insights gained into how lipid metabolism influences their condition, potentially leading to new therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to new treatments targeting lipid metabolism to slow or prevent the progression of Alzheimer's disease.

How similar studies have gone: Previous research has indicated that targeting lipid metabolism may have therapeutic potential in neurodegenerative diseases, suggesting a promising avenue for further exploration.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Yin, Fei — University of Arizona
  • Study coordinator: Yin, Fei

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.